NO993928L - Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium - Google Patents

Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium

Info

Publication number
NO993928L
NO993928L NO993928A NO993928A NO993928L NO 993928 L NO993928 L NO 993928L NO 993928 A NO993928 A NO 993928A NO 993928 A NO993928 A NO 993928A NO 993928 L NO993928 L NO 993928L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
weight
quaternary ammonium
oral administration
heterocyclic compounds
Prior art date
Application number
NO993928A
Other languages
Norwegian (no)
Other versions
NO993928D0 (en
Inventor
Jean-Claude Gautier
Xavier Boulenc
Regine Bellamy
Bernard Abramovici
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO993928L publication Critical patent/NO993928L/en
Publication of NO993928D0 publication Critical patent/NO993928D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Oppfinnelsen angår et farmasøytisk preparat for oral administrering av heterocykliske forbindelser i form av kvaternært ammonium, inneholdende aktivt prinsipp hydrofilt løsemiddel anionisk overflateaktivt middel polysorbat 80 makrogoglycerid QS opptil 0,1 tiM5vekt% O til 60 vekt% O til 5 vekt% O til 5 vekt% 100vekt%, forutsatt at minst en bestanddel valgt fra det hydrofile løsemiddel og anioniske overflateaktive middel er til stede.The invention relates to a pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium containing active principle hydrophilic solvent anionic surfactant polysorbate 80 macrogoglyceride QS up to 0.1% by weight% 0 to 60% by weight 0 to 5% by weight 0 to 5% by weight 100% by weight, provided that at least one component selected from the hydrophilic solvent and anionic surfactant is present.

NO993928A 1997-02-17 1999-08-16 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium NO993928D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701825A FR2759584B1 (en) 1997-02-17 1997-02-17 PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF HETEROCYCLIC COMPOUNDS IN QUATERNARY AMMONIUM FORM
PCT/FR1998/000298 WO1998035662A1 (en) 1997-02-17 1998-02-17 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium

Publications (2)

Publication Number Publication Date
NO993928L true NO993928L (en) 1999-08-16
NO993928D0 NO993928D0 (en) 1999-08-16

Family

ID=9503804

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993928A NO993928D0 (en) 1997-02-17 1999-08-16 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium

Country Status (11)

Country Link
EP (1) EP0969825A1 (en)
JP (1) JP2001511795A (en)
AR (1) AR011805A1 (en)
AU (1) AU6404998A (en)
BR (1) BR9807694A (en)
CA (1) CA2281560A1 (en)
FR (1) FR2759584B1 (en)
HR (1) HRP980075A2 (en)
NO (1) NO993928D0 (en)
WO (1) WO1998035662A1 (en)
ZA (1) ZA981289B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188424B (en) * 2011-03-23 2013-03-27 浙江理工大学 Anti-leukemia effects of SR140333

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (en) * 1991-05-03 1993-09-03 Sanofi Elf AMINO POLYCYCLIC COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2676054B1 (en) * 1991-05-03 1993-09-03 Sanofi Elf NOVEL N-ALKYLENEPIPERIDINO COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2688219B1 (en) * 1992-03-03 1994-07-08 Sanofi Elf AMATONIUM QUATERNARY SALTS OF AMINO AROMATIC COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2696178B1 (en) * 1992-09-30 1994-12-30 Sanofi Elf Quaternary basic amides, process for their preparation and pharmaceutical compositions containing them.
FR2717804B1 (en) * 1994-03-25 1996-06-21 Sanofi Sa Salts of substituted nitrogen heteroaromatic compounds, process for their preparation and pharmaceutical compositions containing them.
ATE177095T1 (en) * 1994-08-25 1999-03-15 Merrell Pharma Inc SUBSTITUTED PIPERIDINE FOR THE TREATMENT OF ALLERGIC DISEASES
FR2725900B1 (en) * 1994-10-21 1997-07-18 Sanofi Sa USE OF NK1 RECEPTOR ANTAGONISTS FOR THE PREPARATION OF DRUGS WITH CARDIOREGULATORY ACTION
FR2725986B1 (en) * 1994-10-21 1996-11-29 Adir NOVEL PIPERIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2729951B1 (en) * 1995-01-30 1997-04-18 Sanofi Sa NOVEL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2729954B1 (en) * 1995-01-30 1997-08-01 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
FR2759584A1 (en) 1998-08-21
EP0969825A1 (en) 2000-01-12
AU6404998A (en) 1998-09-08
CA2281560A1 (en) 1998-08-20
JP2001511795A (en) 2001-08-14
FR2759584B1 (en) 1999-06-11
BR9807694A (en) 2000-03-21
AR011805A1 (en) 2000-09-13
ZA981289B (en) 1998-08-26
NO993928D0 (en) 1999-08-16
WO1998035662A1 (en) 1998-08-20
HRP980075A2 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
NO954146L (en) Coated pharmaceutical preparations
FI973320A (en) Preparations containing solid active substance
DK0449247T3 (en) Pharmaceutical formulation containing galanthamine for the treatment of alcoholism
NO304989B1 (en) 11 <beta> -benzaldoxime- ° stra-4,9-diene derivatives and pharmaceutical preparations containing such
NO20000466L (en) Pharmaceutical preparation for acidic, lipophilic compounds in the form of a self-regulating formulation
ATE202337T1 (en) CYCLOPROPYLALKANIC ACID DERIVATIVES
DE69307977D1 (en) Stabilized derivatives of pharmaceutical compositions containing vitamin D2 and D3
GR1002295B (en) Solid pharmaceutical compositions and preparation method
DK515489D0 (en) DISPERSIBLE PHARMACEUTICAL FORMULATION
DK0648779T3 (en) 11-Benzaldoxime-17beta-methoxy-17alpha-methoxymethyl-estradiene derivatives, processes for their preparation, and drugs containing these compounds
PT1078627E (en) PHARMACEUTICAL FORM COMPOSITIONS FOR AMOXYCYCLINE AND CLAVULANATE
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
NO993928L (en) Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium
ATE316788T1 (en) MEDICINE FOR PULMONARY HEART PROBLEMS
DK0624365T3 (en) Pharmaceutical form for rectal administration of pharmacologically active compounds
IT1272762B (en) BENZ / E / PHARMACEUTICALLY ACTIVE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
DK0986390T3 (en) Pharmaceuticals with cinchosine dihydrochloride
DE69000806D1 (en) INDOL DERIVATIVES.
ATE335491T1 (en) DRUGS FOR GLOMERULOSCLERosis
IT8622579A0 (en) DERIVATIVES OF AZLACTONES, PROCESS FOR THEIR PREPARATION AND PESTICIDES CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT.
FR2659967B1 (en) N-SUBSTITUTED IMIDAZOLINONE DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.
ITMI911653A1 (en) DERIVATIVES OF ESERIDINE FOR ANTI-COLINESTERASE ACTIVITIES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DE69325531T2 (en) Oral medicinal product consisting of ibuprofen
ITMI912324A1 (en) DERIVED FROM BETA-HYDROXYBUTIRRIC ACID, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
TH32101A (en) Indeterminate form of benzothiophene